+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aliskiren"

Global Renin-Inhibitor Market Outlook 2028 - Product Thumbnail Image

Global Renin-Inhibitor Market Outlook 2028

  • Report
  • August 2020
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Aliskiren is a direct renin inhibitor used in the treatment of hypertension and other cardiovascular diseases. It works by blocking the action of renin, an enzyme that helps regulate blood pressure. Aliskiren is typically prescribed in combination with other antihypertensive medications, such as diuretics, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. It is available in both oral and intravenous formulations. Aliskiren has been shown to be effective in reducing blood pressure and improving cardiovascular outcomes. It is generally well-tolerated, with few side effects. However, it is not recommended for use in patients with renal impairment or diabetes. The aliskiren market is highly competitive, with several major pharmaceutical companies offering products. These include Novartis, Merck, Pfizer, and Sanofi. Other companies, such as Daiichi Sankyo and Takeda, also offer aliskiren-based products. Show Less Read more